Stay updated on T-DXd in HER2 Expressing Tumors Clinical Trial

Sign up to get notified when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DXd in HER2 Expressing Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    New locations across the US states, Canadian provinces, and Gurgaon, India were added, and several existing sites were removed.
    Difference
    0.9%
    Check dated 2025-12-24T15:24:55.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The India location entry for 122001 was updated from Gurgaon to Gūrgaon (with a diacritic) to reflect the revised place name.
    Difference
    0.0%
    Check dated 2025-12-17T04:10:19.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The change is limited to updating the page version label from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:40:14.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Recruitment status updated from Active, not recruiting to Recruiting. The page now includes a PubMed publications note and shows revision metadata (Revision: v3.3.1).
    Difference
    0.2%
    Check dated 2025-11-24T14:30:52.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    A new site in Tainan, Taiwan (736) was added. The Tainan City, Taiwan (736) site was removed, altering the geographic footprint of participating centers.
    Difference
    0.2%
    Check dated 2025-11-17T06:32:06.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    Updated the India site entry to correct the spelling from Gūrgaon to Gurgaon, India (PIN 122001).
    Difference
    0.3%
    Check dated 2025-11-03T01:12:02.000Z thumbnail image

Stay in the know with updates to T-DXd in HER2 Expressing Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DXd in HER2 Expressing Tumors Clinical Trial page.